TransCode Therapeutics, Inc. (RNAZ)
10.42
+1.79
(+20.74%)
USD |
NASDAQ |
Dec 11, 16:00
10.06
-0.36
(-3.45%)
After-Hours: 20:00
TransCode Therapeutics Free Cash Flow: -14.52M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Intuitive Surgical, Inc. | 2.271B |
| Eli Lilly & Co. | 6.436B |
| Aquestive Therapeutics, Inc. | -50.94M |
| NovaBay Pharmaceuticals, Inc. | -7.012M |
| Palatin Technologies, Inc. | -15.91M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -4.083M |
| Cash from Financing (Quarterly) | -0.4557M |
| Free Cash Flow Per Share (Quarterly) | -4.898 |
| Free Cash Flow to Equity (Quarterly) | -4.083M |
| Free Cash Flow to Firm (Quarterly) | -4.077M |
| Free Cash Flow Yield | -297.1% |